HMOX1 and systemic lupus erythematosus: In a mouse model of SLE, DCs treated in vitro with HO-1 inducer showed a stable tolerogenic profile, and treatment with these DCs alleviated SLE symptoms, including decreased ANA and reduced skin lesion severity (166).